Desrosiers Nathalie A, Betit Caroline C, Watterson James H
Forensic Toxicology Research Laboratory, Laurentian University, 935 Ramsey Lake Rd., Sudbury, Ontario, Canada P3E 2C6.
Forensic Sci Int. 2009 Jul 1;188(1-3):23-30. doi: 10.1016/j.forsciint.2009.03.008. Epub 2009 Apr 18.
The use of microwave-assisted extraction (MAE) in screening of decomposed bone tissue for model drugs of abuse is described. Rats received 50 mg/kg (i.p.) pentobarbital (n=2), 75 mg/kg (i.p.) ketamine (n=2) or 16 mg/kg (i.p.) diazepam (n=1), or remained drug-free (control). Drug-positive animals were euthanized within 20 min of drug administration. Animal remains were allowed to decompose in a secure outdoor environment to the point of complete skeletonization. Bones (tibiae, femora, vertebrae, ribs, pelvi, humeri and scapulae) were collected and pooled (according to drug) in order to minimize effects due to inter-bone differences in drug distribution. Bones were crushed and cleaned of marrow and residual soft tissue in alkaline solution or phosphate buffer with ultrasonication. Cleaned bones were then ground and underwent MAE in phosphate buffer (pH 6), methanol or a methanol:water mixture (1:1, v/v) at atmospheric pressure in a domestic microwave oven, or passive extraction in methanol. Bone extracts (control and drug-exposed) containing methanol were evaporated to dryness before reconstitution in phosphate buffer (pH 6) and subsequent analysis by ELISA, while bone extracts containing only phosphate buffer were assayed directly by the same ELISA protocol. Measured absorbance values were expressed as the decrease in absorbance, measured as a percentage, relative to the corresponding drug-free control bone extract. The semi-quantitative nature of the ELISA assay allowed examination of the effects of extraction solvent and bone sample mass on the assay response for each drug examined, and subsequent comparison to assays of extracts obtained through passive methanolic extraction of various bone tissues. Overall, the time required for maximal extraction varied with extraction solvent and bone mass for each drug investigated, with significant extraction occurring with all solvent systems examined. MAE may represent a substantially faster extraction system than passive extraction, with significant extraction recovery observed within 1 min of exposure for all samples examined. The implications of these results in the context of the available literature on drug analysis in skeletal tissues are discussed.
本文描述了微波辅助萃取(MAE)在筛选分解骨组织中滥用药物模型方面的应用。大鼠接受50mg/kg(腹腔注射)戊巴比妥(n = 2)、75mg/kg(腹腔注射)氯胺酮(n = 2)或16mg/kg(腹腔注射)地西泮(n = 1),或不使用药物作为对照。用药阳性的动物在给药后20分钟内安乐死。动物遗体置于安全的室外环境中使其分解至完全白骨化。收集骨骼(胫骨、股骨、椎骨、肋骨、骨盆、肱骨和肩胛骨)并根据药物分类汇总,以尽量减少骨骼间药物分布差异的影响。将骨骼粉碎,在碱性溶液或磷酸盐缓冲液中通过超声处理去除骨髓和残留软组织。然后将清洁后的骨骼研磨,并在家庭微波炉中于常压下在磷酸盐缓冲液(pH 6)、甲醇或甲醇:水混合物(1:1,v/v)中进行MAE,或在甲醇中进行被动萃取。含甲醇的骨提取物(对照和用药组)在蒸发至干后用磷酸盐缓冲液(pH 6)复溶,随后通过酶联免疫吸附测定(ELISA)分析,而仅含磷酸盐缓冲液的骨提取物则直接采用相同的ELISA方案进行检测。测得的吸光度值表示为吸光度的下降,以相对于相应无药物对照骨提取物的百分比来衡量。ELISA测定的半定量性质使得能够研究萃取溶剂和骨样品质量对每种检测药物的测定响应的影响,并随后与通过各种骨组织的被动甲醇萃取获得的提取物的测定结果进行比较。总体而言,对于所研究的每种药物,最大萃取所需时间随萃取溶剂和骨质量而变化,在所研究的所有溶剂系统中均出现显著萃取。与被动萃取相比,MAE可能是一种实质上更快的萃取系统,在所检测的所有样品中,暴露1分钟内即可观察到显著的萃取回收率。本文讨论了这些结果在骨骼组织药物分析现有文献背景下的意义。